Curium Announces Approval of Pulmotech™ MAA (kit for the preparation of technetium Tc 99m albumin aggregated injection) by the U.S. Food and Drug Administration St. Louis, MO, March 24, 2020 (GLOBE NEWSWIRE) -- Curium announced today that the U.S. Food and Drug Administration (FDA) has approved Pulmotech MAA.  When labeled to technetium Tc 99m, Pulmotech...

Curium Announces Plan to Submit an Application to Market Generic Ioflupane I 123 Injection in the U.S. St. Louis MO, Nov. 13, 2019 (GLOBE NEWSWIRE) -- Curium announced today that it intends to submit an abbreviated new drug application for a generic version of DaTscanTM (Ioflupane I 123 Injection) in...

Curium Announces Revised Pricing for Technescan MAG3TM St. Louis, Sept. 04, 2019 (GLOBE NEWSWIRE) -- Curium announced today that it is implementing a new pricing model for Technescan MAG3.  Curium is phasing out its pay per dose sales model, in which...